March 23, 2011

HELIX BIOPHARMA CORP. TO PRESENT AT BIT LIFE SCIENCES’ THIRD ANNUAL INTERNATIONAL CONGRESS OF ANTIBODIES IN BEIJING CHINA ON MARCH 25 (PDF)

AURORA, Ontario, MARCH 23, 2011 – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “HBP”), a developer of
biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that Baomin Tian, Ph.D.,
senior scientist, will be presenting at BIT Life Sciences’ third International Congress of Antibodies on March 25, 2011 at the China National Conventional Center, Beijing, China.